Bacteriophages are the most abundant biological entity in the world and hold a tremendous
amount of unexplored genetic information. Since their discovery, phages have drawn a great …

Lateral flow immunoassays (LFIAs) are well-established and broadly commercialized tools
in the field of point-of-care testing due to their simplicity, rapidity, cost-effectiveness, and low …

The disease-related suffering in colorectal cancer remains prevalent despite advancements
in the field of drug delivery. Chemotherapy-related side effects and non-specificity remain a …

Point-of-care testing (POCT) technology, using lateral flow assays and microfluidic systems,
facilitates cost-effective diagnosis, timely treatment, ongoing monitoring, and prevention of …

Phage display enables to screen probes such as peptide, antibody and nanobody with high
specificity and affinity to the target, providing excellent probes for various analytical or …

Nanobiosensors are devices that utilize a very small probe and any form of electrical,
optical, or magnetic technology to detect and analyze a biochemical or biological process …

Nanoparticulate delivery systems have been attracting attention in pharmaceutical sciences
for enhanced drug bioavailability and targeted delivery. Specifically, these systems can …

Abstract Gold Nanoparticles (AuNPs) have gained significant attention in biosensor
development due to their unique physical, chemical, and optical properties. When …

Pathogenic diseases spreading through water and food media are a worldwide concern,
causing substantial mortality and morbidity. The crucial part of controlling the transmission of …

Lab-on-fiber (LoF) optrodes offer several advantages over conventional techniques for point-
of-care platforms aimed at real-time and label-free detection of clinically relevant …